Haematology International Journal
Research Article
1 min read
Ambient or Static-T lymphoblastic Leukaemia/Lymphoma
* Corresponding author
Keywords
Lymphoblastic Lymphoma
Lymphoblastic Leukaemia
Terminal Deoxynucleotidyl Transferase
Abstract
T lymphoblastic leukaemia/lymphoma is a neoplasm engendered from lymphoblast of T cell lineage which may configure lymphomatous tumefaction or incriminate peripheral blood and bone marrow. T lymphoblastic lymphoma (T LBL) appears to arise from thymocytes.
Figures
![Figure 1: T lymphoblastic lymphoma depicting disseminated neoplastic lymphocytes with imbued with scant, basophilic cytoplasm, enlarged nuclei with delicate chromatin, convoluted nuclear membrane, nuclear grooves and indistinct nucleoli [2-5].](/fulltextimages/9932/fig_1.png)
Click to enlarge

Click to enlarge
References
-
Kaseb H, Tariq MA, Gupta G (2022) Lymphoblastic Lymphoma. Stat Pearls International, Treasure Island, Florida.
-
Chen J, Tian X, Yu N, Peng L, Zhu H (2022) T-Cell Lymphoblastic Lymphoma with Cutaneous Involvement in a Child: A Rare Case Report. Clin Cosmet Investig Dermatol 15: 2027-2033.
-
Yu H, Mi L, Qi F, Wang X, Ye Y, et al. (2022) Survival and prognostic analysis of T-cell lymphoblastic lymphoma patients treated with dose-adjusted BFM-90 regimen. Aging (Albany NY) 14(7): 3203-3215.
-
Intermesoli T, Weber A, Leoncin M, Frison L, Skert C, et al. (2022) Lymphoblastic Lymphoma: a Concise Review. Curr Oncol Rep 24(1): 1-12.
-
Image 1 and 2 Courtesy: Doctorlibinfo.com
← Previous Article
Pfizer, Moderna and Janssen vaccine InflammoThrombotic and
Prion Type Effect on Erythrocytes When Added to Human Blood
Next Article →
Abnormal Chromosome in Patients with Multiple Myeloma: A
Cohor Study in Vietnam
More from this journal
- How to Identify and Overcome Barriers in Developing Blood Systems?
- Why Was Transfusion Medicine Not Recognized as a Clinical Discipline?
- Outcomes of Lenalidomide Relapsed/Refractory Patients
- Is Transfusion Always Necessary?
- The Logistics of Production and Use of Blood and Blood Components
- The Challenge for Component Therapies